EUVIMEDEUVIMED entdecken
Crossref

Synthesis, biological evaluation, and In silico molecular docking of N‐(4‐(4‐substitutedphenyl)‐6‐(substituted aryl) pyrimidin‐2‐yl)‐2‐(2‐isonicotinoyl hydrazinyl) acetamide

Hetal I Soni, Navin B Patel, Iqrar Ahmad, Harun Patel, Gildardo Rivera

Journal of Biochemical and Molecular Toxicology · 2024-01 · 38 (1)

DOI: 10.1002/jbt.23634 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 04.01.2024. Verfasst von Hetal I Soni und 4 weiteren Autor:innen. Beteiligte Einrichtung: C. B. Patel Computer College and J. N. M. Patel Science College, Veer Narmad South Gujarat University, Surat, Gujarat, India. Hauptthemen laut MEDLINE: Antimalarials. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: IPR-UGC section.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Isonicotinohydrazide is the first‐line medication in the prevention and treatment of tuberculosis. Antitubercular, antibacterial, antifungal, antiviral, anti‐inflammatory, antimalarial activity, anticancer, antineoplastic activity, and anti‐HIV activity are all demonstrated by drugs with a pyrimidine ring. The current study focuses on the synthesis of N‐(4‐(substituted‐phenyl)‐6‐(substituted‐aryl) pyrimidin‐2‐yl)‐2‐(2‐isonicotinoylhydrazinyl) acetamide from isonicotinohydrazide. Newly synthesized compounds were characterized by spectral studies (IR, 1 H‐NMR, 13 C‐NMR, and mass spectroscopy). They were screened for their antituberculosis, antimalarial, and antiprotozoal activities and compared with standard drugs. Molecular docking of isonicotinohydrazide‐bearing pyrimidine motifs was also done for some of the active compounds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsMolecular Docking SimulationAntitubercular AgentsAnti-Bacterial AgentsIsoniazidPyrimidinesAcetamidesStructure-Activity RelationshipMicrobial Sensitivity Tests

Stichwörter der Autor:innen

antimalarialantiprotozoaantitubercular H37RVisonicotinohydrazidemolecular dockingpyrimidine

Substanzen

AntimalarialsAntitubercular AgentsAnti-Bacterial AgentsIsoniazidPyrimidinesAcetamides

Autor:innen und Institutionen

  • C. B. Patel Computer College and J. N. M. Patel Science College, Veer Narmad South Gujarat University, Surat, Gujarat, India.
  • Department of Pharmaceutical Chemistry, Prof Ravindra Nikam College of Pharmacy, Gondur, Maharashtra, India.
  • R C Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra, India.
  • Laboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Ciudad de Mexico, Mexico.

Förderung

  • IPR-UGC section

Zitieren

APA

Soni, H. I., Patel, N. B., Ahmad, I., Patel, H., & Rivera, G. (2024). Synthesis, biological evaluation, and In silico molecular docking of N‐(4‐(4‐substitutedphenyl)‐6‐(substituted aryl) pyrimidin‐2‐yl)‐2‐(2‐isonicotinoyl hydrazinyl) acetamide. Journal of Biochemical and Molecular Toxicology, 38(1). https://doi.org/10.1002/jbt.23634

Vancouver

Soni HI, Patel NB, Ahmad I, Patel H, Rivera G. Synthesis, biological evaluation, and In silico molecular docking of N‐(4‐(4‐substitutedphenyl)‐6‐(substituted aryl) pyrimidin‐2‐yl)‐2‐(2‐isonicotinoyl hydrazinyl) acetamide. Journal of Biochemical and Molecular Toxicology. 2024;38(1). doi:10.1002/jbt.23634

BibTeX
@article{Soni2024,
  author = {Soni, Hetal I and Patel, Navin B and Ahmad, Iqrar and Patel, Harun and Rivera, Gildardo},
  title = {Synthesis, biological evaluation, and In silico molecular docking of N‐(4‐(4‐substitutedphenyl)‐6‐(substituted aryl) pyrimidin‐2‐yl)‐2‐(2‐isonicotinoyl hydrazinyl) acetamide},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2024},
  volume = {38},
  number = {1},
  doi = {10.1002/jbt.23634}
}
Kostenlos starten →